European Pharmaceutical Review

AUGUST 17, 2022

Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware, US. The WuXi STA Middletown facility is expected to begin operations in 2025.

Manufacturing 96

Manufacturing Pharmaceutical manufacturing Distribution Pharmaceutical 96

European Pharmaceutical Review

DECEMBER 18, 2023

Pharmaceutical manufacturing Oligonucleotides Last month, the Centre for Process Innovation (CPI) announced a new Scotland-based manufacturing facility focusing on oligonucleotide therapeutics. According to CPI, the facility is set to be completed in late 2025.

Manufacturing 98

Manufacturing Food and Drug Administration Medicine Pharmaceutical manufacturing 98

PM360

AUGUST 9, 2022

billion in 2025. One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. NovaXS is on a mission to simplify the medication self-administration process and improve remote healthcare adherence.

Prescription 105

Prescription Medical Patients Side effects 105

Clarivate

AUGUST 20, 2024

In 2025, CMS will select another 15 Part D drugs for negotiations that will take effect in 2027. That compares to the $240.4 billion in spending across all Part D drugs that year (2022) and the $43.6 billion spent on all Part B drugs that same year.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52